Sangamo BioSciences | SGMO - Stock





Stock Veränderung Datum
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amgen USD 6.22B 34M 2026-06
Bayer EUR 12.01B 321M 2026-03
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Cipla INR 65.97B 4.37B 2026-03
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Grifols EUR 3.56B 63.19M 2024-12
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
J&J USD 15.14B 561M 2026-06
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Merck USD 6.21B 272M 2026-06
Novartis USD 6.22B 66M 2026-06
Omeros USD 712K 266K 2021-09
Pfizer USD 9.94B 722M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06